GeneDx Holdings Corp. (WGS)

Real-time intraday values

Market Overview

From:

To:

WGS Intraday

No data available

SymbolWGS

IPO DateNov 4, 2020

CEOMs. Katherine A. Stueland

Full Time Employees1.3k

SectorHealthcare

IndustryDiagnostics & Research

CountryUnited States

ExchangeNasdaqGS

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Performance

Period	Return %	Value Change
1 Day	-14.26%	-12.61 US$
5 Days	-11.04%	-9.41 US$
1 Month	-12.21%	-10.54 US$
6 Months	+15.67%	+10.27 US$

Analyzing Market with AI

Evaluating the last 30 days of history and fundamental metrics of WGS...

Read the latest public AI report for WGS

Key Statistics

Market Cap

2.26B

P/E Ratio

N/A

Div Yield

N/A

52W High

$170.87

52W Low

$32.21

Analyst Consensus

ConsensusStrong Buy

Bullish9100.0%

Neutral00.0%

Bearish00.0%

52W Analyst Price Targets

Min Target
$74.00

Max Target
$103.00

Current$75.79

Avg Target$90.44

Analyst Recommendations

Target Price:$90.44($74.00 - $103.00)

Firm	Rating	Target Price	Upside Potential	Date
Canaccord Genuity	Buy	$90.00	+18.75%	8/4/2026
BTIG	Buy	$90.00	+18.75%	8/4/2026
Guggenheim	Buy	$74.00	-2.36%	6/29/2026
Piper Sandler	Overweight	$63.00	-16.88%	6/23/2026
Canaccord Genuity	Buy	$75.00	-1.04%	5/5/2026
Wells Fargo	Overweight	$75.00	-1.04%	5/5/2026
Guggenheim	Buy	$70.00	-7.64%	5/5/2026
BTIG	Buy	$90.00	+18.75%	5/5/2026
Canaccord Genuity	Buy	$100.00	+31.94%	4/20/2026
Guggenheim	Buy	$100.00	+31.94%	3/30/2026